Clearbridge Investments, LLC Intra Cellular Therapies, Inc. Transaction History

Clearbridge Investments, LLC

$123 Billion
Q3 2024

A detailed history of Clearbridge Investments, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Clearbridge Investments, LLC holds 1,729,729 shares of ITCI stock, worth $148 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,729,729

Previous 1,721,610 0.47%

Holding current value

$148 Million

Previous $118 Million 7.26%

% of portfolio

0.1%

Previous 0.1%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$67.99 - $80.84 $552,010 - $656,339	8,119 Added 0.47%	1,729,729 $126 Million
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $1.49 Million - $1.83 Million	-22,941 Reduced 1.32%	1,721,610 $118 Million
Q1 2024 May 13, 2024	BUY	$64.37 - $75.65 $12.3 Million - $14.5 Million	191,416 Added 12.32%	1,744,551 $121 Million
Q4 2023 Feb 09, 2024	BUY	$46.37 - $73.65 $6.93 Million - $11 Million	149,534 Added 10.65%	1,553,135 $111 Million
Q3 2023 Nov 13, 2023	SELL	$52.09 - $64.1 $528,400 - $650,230	-10,144 Reduced 0.72%	1,403,601 $73.1 Million
Q2 2023 Aug 11, 2023	BUY	$54.67 - $66.44 $19.9 Million - $24.2 Million	363,870 Added 34.66%	1,413,745 $89.5 Million
Q1 2023 May 12, 2023	BUY	$43.8 - $56.99 $17.1 Million - $22.3 Million	390,493 Added 59.22%	1,049,875 $56.9 Million
Q4 2022 Feb 10, 2023	BUY	$44.07 - $54.45 $356,922 - $440,990	8,099 Added 1.24%	659,382 $34.9 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $19 Million - $26.8 Million	446,112 Added 217.43%	651,283 $30.3 Million
Q2 2022 Aug 11, 2022	SELL	$43.0 - $65.64 $1.52 Million - $2.31 Million	-35,257 Reduced 14.66%	205,171 $11.7 Million
Q1 2022 May 13, 2022	SELL	$38.74 - $62.09 $3.52 Million - $5.63 Million	-90,742 Reduced 27.4%	240,428 $14.7 Million
Q4 2021 Feb 11, 2022	SELL	$35.2 - $53.42 $3.6 Million - $5.46 Million	-102,148 Reduced 23.57%	331,170 $17.3 Million
Q3 2021 Nov 12, 2021	SELL	$28.72 - $42.49 $1.15 Million - $1.7 Million	-40,075 Reduced 8.47%	433,318 $16.2 Million
Q2 2021 Aug 13, 2021	SELL	$29.3 - $44.5 $62,086 - $94,295	-2,119 Reduced 0.45%	473,393 $19.3 Million
Q1 2021 May 13, 2021	SELL	$30.8 - $39.51 $4.5 Million - $5.78 Million	-146,233 Reduced 23.52%	475,512 $16.1 Million
Q4 2020 Feb 10, 2021	SELL	$23.34 - $32.22 $578,271 - $798,282	-24,776 Reduced 3.83%	621,745 $19.8 Million
Q3 2020 Nov 12, 2020	BUY	$17.61 - $31.86 $358,874 - $649,274	20,379 Added 3.25%	646,521 $16.6 Million
Q2 2020 Aug 14, 2020	BUY	$14.35 - $26.64 $1.65 Million - $3.06 Million	114,764 Added 22.44%	626,142 $16.1 Million
Q1 2020 May 15, 2020	BUY	$12.31 - $33.12 $2.39 Million - $6.42 Million	193,769 Added 61.01%	511,378 $7.86 Million
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $3.39 Million - $18 Million	-467,529 Reduced 59.55%	317,609 $10.5 Million
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $5.86 Million - $11 Million	785,138 New	785,138 $5.87 Million

Others Institutions Holding ITCI

# of Institutions

377

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.08B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Intra Cellular Therapies, Inc. Transaction History